aTyr Pharma Posts $7.43 Q3 GAAP Loss Per Share, Expects Resources to Fund Operations Into Late 2028

aTyr Pharma, Inc. (Nasdaq: ATYR) posted a $7.43 per-share GAAP loss for the third quarter and expects its current resources to fund operations into late 2028. For the quarter ended Sept. 30, the company reported a GAAP loss per share of $7.43. At Sept. 30, aTyr held $50.3 million in cash, cash equivalents, restricted cash and available-for-sale investments. The company expects that position to support current operations into late 2028, based on its current cash and operating expense outlook and plans.

Source: TokenPost